Lazard Asset Management
TARO

Lazard Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Lazard Asset Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-63
Closed -$4K – 1766
2020
Q2 		$4K Sell
63
-157
-71% -$10.5K ﹤0.01% 1535
2020
Q1 		$13K Buy
+220
New +$16.3K ﹤0.01% 1493
2019
Q4 		– Sell
-171
Closed -$12K – 1696
2019
Q3 		$12K Buy
+171
New +$13.9K ﹤0.01% 1281

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Lazard Asset Management's TARO Position: Q3 2020 in Review

Lazard Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2020, closing a stake of 63 shares — an estimated $4K sold.

Lazard Asset Management first reported a position in TARO in Q3 2019 and held it in 3 quarters. The position peaked at $13K in Q1 2020. 78 funds tracked by Wall St. Rank hold TARO as of Q3 2020.

  • Lazard Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2020 after selling out during the quarter.
  • Lazard Asset Management sold 63 Taro Pharmaceutical Industries Ltd. shares in Q3 2020, an estimated $4K.
  • Lazard Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2019 and held it in 3 quarters.
  • Lazard Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $13K in Q1 2020.
  • 78 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2020.

Based on Lazard Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.